Furthermore, we also verified that VPS35 knockdown sensitises GC cells to the 5-FU and cisplatin, suggesting that the inhibition of VPS35 in combination with 5-FU and cisplatin may represent a potential strategy for treating GC. This evidence concerns the gene VPS35 and gastric cancer.